eTOX Newsletter has been released in March.
Novartis has released OntoBrowser.
Welcome to the eTOX Website
The eTOX project aims to develop a drug safety database from the pharmaceutical industry legacy toxicology reports and public toxicology data; innovative in silico strategies and novel software tools to better predict the toxicological profiles of small molecules in early stages of the drug development pipeline
eTOX, under Grant Agreement nš115002, is funded by the Innovative Medicines Initiative Joint Undertaking (IMI-JU), a unique partnership between the European Community and the European Federation of Pharmaceutical Industries and Associations (EFPIA).
eTOX Project extension (ENSO) has been approved by IMI.
See more details here.